Delivery Order SPE2DB22D3011-SPE2DB25FQ0VG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,622.82 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for ultimate completion by June 18, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $33,369.67 to supply Entresto 24 mg-26 mg tablets (180-count units). This non-competitive, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a standard pharmaceutical supply transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $38,756.30 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,294.80 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count packages) under a firm fixed-price contract. The award was made on April 21, 2025, with an ultimate completion date of April 22, 2025, and represents a non-set-aside, competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $37,426.25 firm fixed-price delivery order on June 6, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This non-set-aside, competitively awarded contract is scheduled for completion by June 9, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $24,605.54 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract type. This delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $45,433.69 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,849.59 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count package). This firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $83,524.51 on July 22, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) with a ceiling value of $15,577.90. This firm fixed-price delivery order, with an ultimate completion date of April 22, 2025, represents a non-set-aside competitive award executed under DLA's broader pharmaceutical supply chain. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ0VGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,809.30 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract. The award was announced on May 12, 2025, with an ultimate completion date of May 13, 2025, and represents a non-competitive award executed under an existing contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. The company's consistent receipt of competitively awarded contracts demonstrates its capability to meet federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.8k | 5/12/25 |